De Mello RA - Search Results

1

Castro D, Moreira M, Gouveia AM, Pozza DH, De Mello RA. Castro D, et al. Among authors: de mello ra. Oncotarget. 2017 Sep 16;8(46):81679-81685. doi: 10.18632/oncotarget.20955. eCollection 2017 Oct 6. Oncotarget. 2017. PMID: 29113423 Free PMC article. Review.

2

Retinoblastoma and p53 protein expression in pre-malignant oral lesions and oral squamous cell carcinoma.

de Oliveira MG, Ramalho LM, Gaião L, Pozza DH, de Mello RA. de Oliveira MG, et al. Among authors: de mello ra. Mol Med Rep. 2012 Jul;6(1):163-6. doi: 10.3892/mmr.2012.876. Epub 2012 Apr 18. Mol Med Rep. 2012. PMID: 22576742

3

Targeting HER family in HER2-positive metastatic breast cancer: potential biomarkers and novel targeted therapies.

Monteiro Ide P, Madureira P, de Vasconscelos A, Pozza DH, de Mello RA. Monteiro Ide P, et al. Among authors: de mello ra, de vasconscelos a. Pharmacogenomics. 2015;16(3):257-71. doi: 10.2217/pgs.14.133. Pharmacogenomics. 2015. PMID: 25712189 Review.

4

Epigenetic therapy in urologic cancers: an update on clinical trials.

Faleiro I, Leão R, Binnie A, de Mello RA, Maia AT, Castelo-Branco P. Faleiro I, et al. Among authors: de mello ra. Oncotarget. 2017 Feb 14;8(7):12484-12500. doi: 10.18632/oncotarget.14226. Oncotarget. 2017. PMID: 28036257 Free PMC article. Review.

5

Lung cancer: a brief review of epidemiology and screening.

Gouvinhas C, De Mello RA, Oliveira D, Castro-Lopes JM, Castelo-Branco P, Dos Santos RS, Hespanhol V, Pozza DH. Gouvinhas C, et al. Among authors: de mello ra. Future Oncol. 2018 Mar;14(6):567-575. doi: 10.2217/fon-2017-0486. Epub 2018 Feb 8. Future Oncol. 2018. PMID: 29417838 Review.

6

Comparative outcome assessment of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small-cell lung cancer: a network meta-analysis.

De Mello RA, Escriu C, Castelo-Branco P, Cabral PL, Mountzios G, Lopes GL, Madureira P. De Mello RA, et al. Oncotarget. 2017 Dec 23;9(14):11805-11815. doi: 10.18632/oncotarget.23668. eCollection 2018 Feb 20. Oncotarget. 2017. PMID: 29545937 Free PMC article.

7

MetaLanc9 as a novel biomarker for non-small cell lung cancer: promising treatments via a PGK1-activated AKT/mTOR pathway.

De Mello RA, Aguiar PN, Tadokoro H, Farias-Vieira TM, Castelo-Branco P, de Lima Lopes G, Pozza DH. De Mello RA, et al. Among authors: de lima lopes g. J Thorac Dis. 2018 Jun;10(Suppl 17):S2076-S2078. doi: 10.21037/jtd.2018.04.122. J Thorac Dis. 2018. PMID: 30023123 Free PMC article. No abstract available.

8

What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?

De Mello RA, Castelo-Branco L, Castelo-Branco P, Pozza DH, Vermeulen L, Palacio S, Salzberg M, Lockhart AC. De Mello RA, et al. Am Soc Clin Oncol Educ Book. 2018 May 23;38:249-261. doi: 10.1200/EDBK_198805. Am Soc Clin Oncol Educ Book. 2018. PMID: 30231398 Free article. Review.

9

The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer.

De Mello RA, Neves NM, Amaral GA, Lippo EG, Castelo-Branco P, Pozza DH, Tajima CC, Antoniou G. De Mello RA, et al. J Clin Med. 2020 Jun 19;9(6):1918. doi: 10.3390/jcm9061918. J Clin Med. 2020. PMID: 32575417 Free PMC article. Review.

10

MicroRNAs in Lung Cancer Oncogenesis and Tumor Suppression: How it Can Improve the Clinical Practice?

Pozza DH, De Mello RA, Araujo RLC, Velcheti V. Pozza DH, et al. Among authors: de mello ra. Curr Genomics. 2020 Aug;21(5):372-381. doi: 10.2174/1389202921999200630144712. Curr Genomics. 2020. PMID: 33093800 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters